Pannexin2 as a novel growth regulator in C6 glioma cells

Oncogene

Volumn 28, Issue 49, 2009, Pages 4402-4408

  Lai, C P K ^a   Bechberger, J F ^a   Naus, C C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

C6 glioma; Gap junction; Intercellular communication; Pannexins; Panx2

Indexed keywords

GAP JUNCTION PROTEIN; PANNEXIN 2; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; ASTROCYTE; CARCINOGENICITY; CELL COMMUNICATION; CELL CONTACT; DOWN REGULATION; GLIOMA CELL; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL LINE; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CONNEXINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; MICE, SCID; MICE, TRANSGENIC; RATS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

RATTUS;

EID: 72049084500     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.283     Document Type: Article

References (38)

1. Baranova A, Ivanov D, Petrash N, Pestova A, Skoblov M, Kelmanson I et al. (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83: 706-716.
2. Barth RF. (1998). Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36: 91-102.
3. Berthoud VM, Minogue PJ, Laing JG, Beyer EC. (2004). Pathways for degradation of connexins and gap junctions. Cardiovasc Res 62: 256-267.
4. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P et al. (2005). Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardi-ovasc Res 67: 234-244.
5. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. (2005). Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem 92: 1033-1043.
6. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA 100: 13644-13649.
7. Chiarugi P, Giannoni E. (2008). Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364.
8. D'Abaco GM, Kaye AH. (2007). Integrin-linked kinase: a potential therapeutic target for the treatment of glioma. J Clin Neurosci 14: 1041-1048.
9. Das SJ, Das S, Koval M. (2005). Regulation of connexin43 oligomerization is saturable. Cell Commun Adhes 12: 237-247.
10. Hu J, Jiang CC, Ng HK, Pang JC, Tong CY, Chen SQ. (2004). A genome-wide allelotype study of primary and corresponding recurrent glioblastoma multiforme in one patient. Chin Med J (Engl) 117: 456-458.
11. Huang YJ, Maruyama Y, Dvoryanchikov G, Pereira E, Chaudhari N, Roper SD. (2007). The role of pannexin 1 hemichannels in ATP release and cell-cell communication in mouse taste buds. Proc Natl Acad Sci USA 104: 6436-6441.
12. Ino Y, Silver JS, Blazejewski L, Nishikawa R, Matsutani M, von Deimling A et al. (1999). Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. J Neuropathol Exp Neurol 58: 881-885.
13. Lai CP, Bechberger JF, Thompson RJ, MacVicar BA, Bruzzone R, Naus CC. (2007). Tumor-suppressive effects of pannexin 1 in C6 glioma cells. Cancer Res 67: 1545-1554.
14. Laing JG, Tadros PN, Westphale EM, Beyer EC. (1997). Degradation of connexin43 gap junctions involves both the proteasome and the lysosome. Exp Cell Res 236: 482-492.
15. Lee AS. (2005). The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35: 373-381.
16. Li H, Brodsky S, Kumari S, Valiunas V, Brink P, Kaide J et al. (2002). Paradoxical overexpression and translocation of connexin43 in homocysteine-treated endothelial cells. Am J Physiol Heart Circ Physiol 282: H2124-H2133.
17. Litvin O, Tiunova A, Connell-Alberts Y, Panchin Y, Baranova A. (2006). What is hidden in the pannexin treasure trove: the sneak peek and the guesswork. J Cell Mol Med 10: 613-634.
18. Locovei S, Bao L, Dahl G. (2006). Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA 103: 7655-7659.
19. Loewenstein WR. (1987). The cell-to-cell channel of gap junctions. Cell 48: 725-726.
20. Mesnil M. (2002). Connexins and cancer. Biol Cell 94: 493-500.
21. Naus CC. (2002). Gap junctions and tumour progression. Can J Physiol Pharmacol 80: 136-141.
22. Naus CC, Bechberger JF, Caveney S, Wilson JX. (1991). Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci Lett 126: 33-36.
23. Naus CC, Goldberg GS, Sin WC. (2005). Connexins in growth control and cancer. In: Winterhager E (ed). Gap Junctions in Development and Disease. Springer-Verlag: Heidelberg, pp. 253-273.
24. Oskam NT, Bijleveld EH, Hulsebos TJ. (2000). A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Int J Cancer 85: 336-339.
25. Pelegrin P, Surprenant A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25: 5071-5082.
26. Pelegrin P, Surprenant A. (2007). Pannexin-1 couples to maitotoxin-and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem 282: 2386-2394.
27. Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. (2003). Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and-competent breast tumor cells. J Biol Chem 278: 30005-30014.
28. Ray A, Zoidl G, Wahle P, Dermietzel R. (2006). Pannexin expression in the cerebellum. Cerebellum 5: 189-192.
29. Romanov RA, Rogachevskaja OA, Bystrova MF, Jiang P, Margolskee RF, Kolesnikov SS. (2007). Afferent neurotransmission mediated by hemichannels in mammalian taste cells. EMBO J 26: 657-667.
30. Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G. (2007). Connexin 43 in ischemic pre-and postcondition-ing. Heart Fail Rev 12: 261-266.
31. Skerrett IM, Di WL, Kasperek EM, Kelsell DP, Nicholson BJ. (2004). Aberrant gating, but a normal expression pattern, underlies the recessive phenotype of the deafness mutant Connexin26M34T. FASEB J 18: 860-862.
32. Thomas T, Jordan K, Simek J, Shao Q, Jedeszko C, Walton P et al. (2005). Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci 118: 4451-4462.
33. Thompson RJ, Zhou N, MacVicar BA. (2006). Ischemia opens neuronal gap junction hemichannels. Science 312: 924-927.
34. Trosko JE, Ruch RJ. (2002). Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 3: 465-482.
35. Vogt A, Hormuzdi SG, Monyer H. (2005). Pannexin1 and Pannexin2 expression in the developing and mature rat brain. Brain Res Mol Brain Res 141: 113-120.
36. Wang XH, Streeter M, Liu YP, Zhao HB. (2008). Identification and characterization of pannexin expression in the mammalian cochlea. J Comp Neurol 512: 336-346.
37. Zappala A, Li VG, Serapide MF, Pellitteri R, Falchi M, La Delia F et al. (2007). Expression of pannexin2 protein in healthy and ischemized brain of adult rats. Neuroscience 148: 653-667.
38. Zheng X, Shen G, Yang X, Liu W. (2007). Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67: 3691-3697.